Insights On Quality Control
-
Host Cell Impurities, Bioassays, Micro-Flow Imaging
4/9/2024
Ensuring the safety and efficacy of cutting-edge biopharmaceuticals hinges on meticulous quality control measures. Explore the role of qPCR and MFI in safeguarding drugs from potential contamination.
-
The Problems With Construction Quality In Life Sciences
11/7/2023
In the mission-critical construction industry, quality management is underperforming. Understand the importance of quality control in life sciences commissioning processes and construction programs.
-
Data Intelligence Requires An Intelligent, Data-Driven Approach To Digital Transformation
5/9/2024
An intelligent and data-driven digital transformation is the key to data intelligence. Discover how in 5 simple steps.
-
Improving Safety And Efficacy With Charged Variant Characterization
5/14/2024
Discover how a CDMO with extensive experience in protein variant characterization, CQA analytics, and patient-centric product development can ensure the safety and efficacy of your biotherapeutic.
-
Nitrosamine Impurities Deadline: Are Your Products Compliant?
11/6/2023
The FDA nitrosamine contamination guidance set deadlines of Nov. 1, 2023, for risk assessment updates and Aug. 1, 2025, for full NDSRI limit compliance.
-
Optimize QC Labs To Increase Right First Time And Reduce Complexity
5/7/2024
Discover a laboratory information management system that optimizes QC laboratories by increasing right-first-time and reducing complexity.
-
Nitrosamine Impurities Deadline: Are Your Products Compliant?
12/5/2023
Learn how to select an experienced nitrosamine mitigation provider and how a tailored, quantified strategy can help you bring your product into compliance while maintaining control of the process.
-
Let The Future Start Today: Development Of Better LNP-Based Genetic Medicines
11/8/2022
Discover how you can accelerate the time to patients for new vaccines and therapies with innovative, streamlined technology that is quicker and more intuitive.
-
Detecting Drug-Excipient Incompatibility In Pharmaceuticals
5/5/2023
Here, we focus on how the apparent melting approach can provide a rapid screening protocol for the detection and analysis of drug-excipient incompatibility in mixtures and formulas.
-
Consolidating The Supply Chain For mRNA
2/12/2024
Learn about the first end-to-end cGMP facility that was developed for mRNA manufacturing to address the shortage of CDMOs and the inadequate and inefficient supply chain options for sourcing GMP mRNA.